3 ms·

I don't know if Parabiosis will eventually prove to have any use in fighting any sort of disease ever, but what I can tell from this article is that I wouldn't

I don't know if Parabiosis will eventually prove to have any use in fighting any sort of disease ever, but what I can tell from this article is that I wouldn't trust that company as far as I can throw it. Just the thought that someone running a medical company thinks he can gather evidence worth talking about by just observing old people who got blood transfusions tells you all you need to know. He's willing to completely fabricate claims about the benefits of this treatment. We now how much of a nightmare Theranos was -and that was a relatively passive procedure they were selling. What happens when this scrappy start up skimps on the screening tests for their donors and end up with venereal diseases in their blood supply? The old 'fake it till you make it' doesn't fly here.

SiempreViernes 8y ago
You think that was an impressive red flag? Then check this out: dismissing objections about effectiveness and safety from the researcher whose experiment is held up on their landing page as a proof of the treatment benefits! https://nordic.businessinsider.com/researchers-say-ambrosia-young-blood-transfusion-startup-putting-lives-at-risk-2018-9?r=US&IR=T https://nordic.businessinsider.com/researchers-say-ambrosia-...
barry-cotter 8y ago
> Just the thought that someone running a medical company thinks he can gather evidence worth talking about by just observing old people who got blood transfusions tells you all you need to know. He's willing to completely fabricate claims about the benefits of this treatment. Indeed, we all know that it’s impossible to develop any kind of scientific knowledge outside randomised control trials. That’s why no one has any scientific opinions on the health effects of smoking tobacco or the long term effects of lead exposure on humans. Without RCTs there’s no way to be sure.
throwaway5752 8y ago
Stanford needs to start a semester long required ethics course, this is vile.

SiempreViernes 8y ago

You think that was an impressive red flag? Then check this out: dismissing objections about effectiveness and safety from the researcher whose experiment is held up on their landing page as a proof of the treatment benefits! https://nordic.businessinsider.com/researchers-say-ambrosia-young-blood-transfusion-startup-putting-lives-at-risk-2018-9?r=US&IR=T https://nordic.businessinsider.com/researchers-say-ambrosia-...

barry-cotter 8y ago

> Just the thought that someone running a medical company thinks he can gather evidence worth talking about by just observing old people who got blood transfusions tells you all you need to know. He's willing to completely fabricate claims about the benefits of this treatment. Indeed, we all know that it’s impossible to develop any kind of scientific knowledge outside randomised control trials. That’s why no one has any scientific opinions on the health effects of smoking tobacco or the long term effects of lead exposure on humans. Without RCTs there’s no way to be sure.

throwaway5752 8y ago

Stanford needs to start a semester long required ethics course, this is vile.